ABCD is setting up a nationwide audit of tirzepatide (Mounjaro) in real clinical use in the UK. The aim will be to ascertain whether the experience in real clinical use matches the data from phase 3 clinical trials.

About the ABCD tirzepatide audit

The ABCD audit programme featured at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2025) which was held on 19-22 March 2025 in Amsterdam, Holland.

Testosterone replacement therapy improves glycaemic control and symptoms in men with type 2 diabetes - the ABCD Worldwide Audit

Authors:

T. Hugh Jones, Karim Haider, Ahmed Haider, Umesh Dashora, Robert E, J. Ryder

Incidence and factors associated with restoration of hypoglycaemia awareness in adults with type 1 diabetes treated with hybrid closed-loop in the United Kingdom: Results from the ABCD audit.

Authors:

Alexandros L Liarakos, Thomas SJ Crabtree, Tomás P Griffin, Yew W Yap, Parth Narendran, Muhammad Ali Karamat, Geraldine Gallen, Sufyan Hussain, Jackie Elliott, Lalantha Leelarathna, Alistair Lumb, Robert EJ Ryder, Pratik Choudhary, Emma G Wilmot on behalf of all ABCD Closed-Loop Pilot audit contributors

Please note this programme is subject to change